Seed data — not verified. Approximate data from public sources, not yet confirmed by cohort leads or site reps.

Why?
All validation packs

Cohort validation pack

COPE

COVID-19 Clinical Neuroscience Study (COVID-CNS)

Generated 6 Oct 2026, 10:36 · ID 60

Unverified

Last verified: 16/04/2026

Instructions for reviewers

  • Review each field against your knowledge of this cohort. Mark Accurate if the value is right, Needs correction if it is wrong or inaccurate (add notes), Not sure if you cannot verify it, or Does not apply if the field is not relevant.
  • Evidence shown is from our source registry. Fields marked No source yet hold values we could not yet pin to a document — those were AI-inferred and need your input most. Fields marked Searched — not published are ones we looked for and could not find publicly; the note lists where we checked.
  • Your selections and notes are kept in this browser tab only (not sent to the database). Print or save as PDF when finished, then return it to the DIGIT team.

Overview

76

Total fields

48

Field-cited

0

Whole-record source only

7

AI-inferred, no source yet

16

Searched — not published

21

No value held

23

Needs review

Source coverage

Summary of how well fields in this pack are linked to evidence.

FieldCurrent valueEvidenceSource evidenceResponseNotes / correction
Field-level source coverage

Optional

48 of 71 reviewable fields are cited to a source (68%) · 7 with no source yet · 16 searched — not published · 21 with no value heldComputed

No citation linked to this field yet.

Response for Field-level source coverage

Identity and ownership

FieldCurrent valueEvidenceSource evidenceResponseNotes / correction
Short name

Required

COPEField-cited
  • DIGIT — data-population-plan.md (in-repo cohort inventory)

    Section: Group 3 (16)

    “**Group 3 (16):** Our Future Health, ALSPAC, PROTECT, ELSA, MCS, Understanding Society, RADAR-MDD, Whitehall II, NCDS 1958, BCS70, COPE, McPin, REACT, ZOE Health, ARC cohorts (pooled), National Maternity Dataset”
Response for Short name
Full name

Required

COVID-19 Clinical Neuroscience Study (COVID-CNS)Field-cited
  • ISRCTN API — ISRCTN47912798 (COVID-CNS)

    https://www.isrctn.com/api/query/format/default?q=47912798&limit=5

    Section: scientificTitle

    “Neurological and psychiatric complications of COVID-19 in hospitalised patients and the neurological, psychiatric and cognitive sequelae: the COVID-19 Clinical Neuroscience Study (COVID-CNS)”

    Page: https://www.isrctn.com/ISRCTN47912798

Response for Full name
Managing organisation

Recommended

University of Liverpool / King's College London (joint lead)Field-cited
  • King's College London — news: national COVID neuro study launch

    https://www.kcl.ac.uk/news/new-national-study-into-neurological-impact-of-covid-19

    Section: application/ld+json abstract

    “Researchers from the University of Liverpool and King's College London today launch a £2.84 million study to investigate the neurological and neuropsychiatric effects of COVID-19.”

    Page: https://www.kcl.ac.uk/news/new-national-study-into-neurological-impact-of-covid-19

  • NIHR BioResource — NBR224 (COVID-CNS)

    https://www.bioresource.nihr.ac.uk/studies/nbr224/

    Section: Summary

    “The COVID-19 Clinical Neuroscience Study (COVID-CNS) is a jointly led study by researchers at the University of Liverpool and King's College London.”

    Page: https://www.bioresource.nihr.ac.uk/studies/nbr224/

Response for Managing organisation
Primary site

Recommended

University of Liverpool (site #28)Field-cited
  • ISRCTN API — ISRCTN47912798 (COVID-CNS)

    https://www.isrctn.com/api/query/format/default?q=47912798&limit=5

    Section: trialCentres / name

    “University of Liverpool”

    Page: https://www.isrctn.com/ISRCTN47912798

Response for Primary site
Website URL

Recommended

https://www.liverpool.ac.uk/covid-clinical-neuroscience-study/Field-cited
  • University of Liverpool — COVID-19 Clinical Neuroscience Study (about)

    https://www.liverpool.ac.uk/covid-clinical-neuroscience-study/about/

    Section: Canonical programme URL

    “https://www.liverpool.ac.uk/covid-clinical-neuroscience-study/”

    Page: https://www.liverpool.ac.uk/covid-clinical-neuroscience-study/about/

Response for Website URL
Catalogue of Mental Health Measures URL

Recommended

No value heldNo source yet

No citation linked to this field yet.

Response for Catalogue of Mental Health Measures URL
Contact name

Recommended

Dr Benedict Michael (Liverpool) and Prof Gerome Breen (KCL)Field-cited
Response for Contact name
Contact email

Recommended

covidcns@liverpool.ac.ukField-cited
Response for Contact email

Summary and status

FieldCurrent valueEvidenceSource evidenceResponseNotes / correction
Description

Required

UK hospitalised adult case–control programme studying acute neurological and psychiatric complications of COVID-19 and medium-term neurological, cognitive and psychiatric sequelae. In-depth clinical assessment, blood biomarkers (inflammation and CNS injury markers) and brain MRI in a subset, with participants consented via NIHR BioResource infrastructure.Field-cited
  • ISRCTN API — ISRCTN47912798 (COVID-CNS)

    https://www.isrctn.com/api/query/format/default?q=47912798&limit=5

    Section: intervention/description

    “All patients will be consented into existing NIHR BioResource infrastructure for long-term sustainability of follow-up.”

    Page: https://www.isrctn.com/ISRCTN47912798

Response for Description
Total N

Required

818Field-cited
  • NIHR BioResource — NBR224 (COVID-CNS)

    https://www.bioresource.nihr.ac.uk/studies/nbr224/

    Section: Potential benefit to patients

    “The COVID-CNS study recruited just over 800 participants—including COVID positive controls and COVID positive cases of neurological complications.”

    Page: https://www.bioresource.nihr.ac.uk/studies/nbr224/

  • University of Liverpool — COVID-19 Clinical Neuroscience Study (about)

    https://www.liverpool.ac.uk/covid-clinical-neuroscience-study/about/

    Section: BioResource / COVID-19 programme

    “recall of the data and samples from the 8,000 who have already joined, including 818 via COVID-CNS are accessible by researchers.”

    Page: https://www.liverpool.ac.uk/covid-clinical-neuroscience-study/about/

Response for Total N
Total N qualifier

Recommended

approximateField-cited
  • University of Liverpool — COVID-19 Clinical Neuroscience Study (about)

    https://www.liverpool.ac.uk/covid-clinical-neuroscience-study/about/

    Section: BioResource / COVID-19 programme

    “including 818 via COVID-CNS”

    Page: https://www.liverpool.ac.uk/covid-clinical-neuroscience-study/about/

Response for Total N qualifier
Year established

Recommended

2020Field-cited
Response for Year established
Active cohort

Recommended

NoField-cited
  • University of Liverpool — COVID-19 Clinical Neuroscience Study (about)

    https://www.liverpool.ac.uk/covid-clinical-neuroscience-study/about/

    Section: BioResource / COVID-19 programme

    “The COVID-19 BioResource is no longer actively recruiting COVID patients”

    Page: https://www.liverpool.ac.uk/covid-clinical-neuroscience-study/about/

Response for Active cohort
Ongoing recruitment

Recommended

NoField-cited
Response for Ongoing recruitment
Refreshed cohort

Recommended

YesField-cited
  • ISRCTN API — ISRCTN47912798 (COVID-CNS)

    https://www.isrctn.com/api/query/format/default?q=47912798&limit=5

    Section: intervention/description

    “Follow-up data will be obtained by face-to-face assessment at 3-9 months post-discharge for:”

    Page: https://www.isrctn.com/ISRCTN47912798

Response for Refreshed cohort

Recontact success rate

Recommended

No value heldNot published
  • Searched — not published

    UNSOURCEABLE: no public recontact success statistic located.

Response for Recontact success rate

Retention rate

Recommended

No value heldNot published
  • Searched — not published

    UNSOURCEABLE: no single headline retention percentage extracted.

Response for Retention rate

Published references

Recommended

doi:10.1038/s41598-024-80833-0Field-cited
  • Shil et al. — COVID-CNS outcomes (Scientific Reports, 2025)

    https://doi.org/10.1038/s41598-024-80833-0

    Section: application/ld+json headline

    “Patients with neurological or psychiatric complications of COVID-19 have worse long-term functional outcomes: COVID-CNS—A multicentre case–control study”

    Page: https://doi.org/10.1038/s41598-024-80833-0

Response for Published references
Notes

Recommended

DIGIT short name “COPE” tracks the COVID neuropsychiatric priority cohort listed as “COPE” in data-population-plan.md and refers to COVID-CNS (not the separate Coronavirus Outbreak Psychological Experiences online survey). Recruitment target text cites ~800 cases plus controls; NIHR BioResource page states just over 800 participants joined; the Liverpool programme page states 818 participants joined via COVID-CNS through the COVID-19 BioResource.Field-cited
  • University of Liverpool — COVID-19 Clinical Neuroscience Study (about)

    https://www.liverpool.ac.uk/covid-clinical-neuroscience-study/about/

    Section: BioResource / COVID-19 programme

    “including 818 via COVID-CNS”

    Page: https://www.liverpool.ac.uk/covid-clinical-neuroscience-study/about/

Response for Notes

3D cohort mapping

Consent, characterisation, and data availability axes used on the cohort map.

FieldCurrent valueEvidenceSource evidenceResponseNotes / correction
Consent level (axis)

Required

3 — Broad consent (recontactable for future studies)Field-cited
  • ISRCTN API — ISRCTN47912798 (COVID-CNS)

    https://www.isrctn.com/api/query/format/default?q=47912798&limit=5

    Section: intervention/description

    “All patients will be consented into existing NIHR BioResource infrastructure for long-term sustainability of follow-up.”

    Page: https://www.isrctn.com/ISRCTN47912798

Response for Consent level (axis)
Characterisation depth (axis)

Required

3 — Multi-domain MH characterisationField-cited
  • ISRCTN API — ISRCTN47912798 (COVID-CNS)

    https://www.isrctn.com/api/query/format/default?q=47912798&limit=5

    Section: intervention/description

    “2.1. CNS-NeuroCog Protocol (built on UK BioBank, the MOCA/MMSE, CAMCOG, and CANTAB tools; piloted on 50). 2.2. NIHR BioResource COPING Protocol (an extended UK Biobank questionnaire covering neurological, cognitive, and psychiatry symptoms, already completed in >30,000).”

    Page: https://www.isrctn.com/ISRCTN47912798

Response for Characterisation depth (axis)
Data availability (axis)

Required

4 — Multi-modalField-cited
  • ISRCTN API — ISRCTN47912798 (COVID-CNS)

    https://www.isrctn.com/api/query/format/default?q=47912798&limit=5

    Section: intervention/description

    “Neuroimaging”

    Page: https://www.isrctn.com/ISRCTN47912798

Response for Data availability (axis)
Cohort map group (derived)

Recommended

Group 1Internal

Internal catalogue field

——
Population type

Recommended

ClinicalNot published
  • DIGIT Cohort Portfolio Review — population type and engagement classification (Aug 2026)

Response for Population type
Industry engagement status

Recommended

UnknownNot published
  • Searched — not published

    UNSOURCEABLE: industry engagement status is an organisational property of the custodian and is not publicly documented; default 'unknown' pending a cohort-owner meeting.

Response for Industry engagement status
Parent cohort / programme

Recommended

No value heldNo source yet

No citation linked to this field yet.

Response for Parent cohort / programme
TWiCs eligible

Recommended

NoField-cited
Response for TWiCs eligible

Data modalities

FieldCurrent valueEvidenceSource evidenceResponseNotes / correction
Questionnaire / interview

Recommended

YesField-cited
  • ISRCTN API — ISRCTN47912798 (COVID-CNS)

    https://www.isrctn.com/api/query/format/default?q=47912798&limit=5

    Section: intervention/description

    “NIHR BioResource COPING Protocol (an extended UK Biobank questionnaire covering neurological, cognitive, and psychiatry symptoms, already completed in >30,000).”

    Page: https://www.isrctn.com/ISRCTN47912798

Response for Questionnaire / interview
Cognitive testing

Recommended

YesField-cited
Response for Cognitive testing
Physical measures

Recommended

YesField-cited
  • ISRCTN API — ISRCTN47912798 (COVID-CNS)

    https://www.isrctn.com/api/query/format/default?q=47912798&limit=5

    Section: plainEnglishSummary

    “The study team will conduct an in depth clinical, laboratory, and imaging study.”

    Page: https://www.isrctn.com/ISRCTN47912798

Response for Physical measures
Biosamples

Recommended

YesField-cited
Response for Biosamples
Genomic data

Recommended

YesField-cited
  • ISRCTN API — ISRCTN47912798 (COVID-CNS)

    https://www.isrctn.com/api/query/format/default?q=47912798&limit=5

    Section: studyHypothesis

    “Similar, but milder neurological symptoms are reported in the community population who have had COVID-19 and are predicted by polygenic scores.”

    Page: https://www.isrctn.com/ISRCTN47912798

Response for Genomic data
Omics

Recommended

YesField-cited
  • ISRCTN API — ISRCTN47912798 (COVID-CNS)

    https://www.isrctn.com/api/query/format/default?q=47912798&limit=5

    Section: secondaryOutcome

    “Cytokine/chemokine profiles measured by luminex from samples at baseline and follow-up”

    Page: https://www.isrctn.com/ISRCTN47912798

Response for Omics
Imaging

Recommended

YesField-cited
Response for Imaging
Wearable / sensor

Recommended

NoField-cited
  • ISRCTN API — ISRCTN47912798 (COVID-CNS)

    https://www.isrctn.com/api/query/format/default?q=47912798&limit=5

    Section: intervention/description

    “Follow-up data will be obtained by face-to-face assessment at 3-9 months post-discharge for:”

    Page: https://www.isrctn.com/ISRCTN47912798

Response for Wearable / sensor
Digital phenotyping

Recommended

NoField-cited
Response for Digital phenotyping
Linked health records

Recommended

NoField-cited
  • ISRCTN API — ISRCTN47912798 (COVID-CNS)

    https://www.isrctn.com/api/query/format/default?q=47912798&limit=5

    Section: inclusion

    “Admitted to a UK hospital during the COVID-19 pandemic”

    Page: https://www.isrctn.com/ISRCTN47912798

Response for Linked health records
Biosample types

Recommended

bloodField-cited
  • University of Liverpool — COVID-19 Clinical Neuroscience Study (about)

    https://www.liverpool.ac.uk/covid-clinical-neuroscience-study/about/

    Section: What is the study?

    “in-depth clinical, laboratory, and imaging studies”

    Page: https://www.liverpool.ac.uk/covid-clinical-neuroscience-study/about/

Response for Biosample types
Genotyping platform

Recommended

No value heldNot published
  • Searched — not published

    UNSOURCEABLE: polygenic score work is referenced at protocol level without a named genotyping array on reviewed pages.

Response for Genotyping platform
Imaging modalities

Recommended

structural_mriField-cited
  • ISRCTN API — ISRCTN47912798 (COVID-CNS)

    https://www.isrctn.com/api/query/format/default?q=47912798&limit=5

    Section: secondaryOutcome

    “Volume of T2 FLAIR signal measured from brain magnetic resonance imaging at baseline and follow-up”

    Page: https://www.isrctn.com/ISRCTN47912798

Response for Imaging modalities
Mental health measures

Recommended

MoCA, MMSE, CAMCOG, CANTAB, UK Biobank questionnaire (neuro/psych items)Field-cited
Response for Mental health measures

Data subcategories

Structured modality and subcategory rows used alongside the high-level data-type flags.

FieldCurrent valueEvidenceSource evidenceResponseNotes / correction

Data subcategories

Recommended

List key data subcategories using distinct rows for category markers, named questionnaire/interview instruments, biospecimen types, omics/genomics data products, imaging modalities, sensor streams, and linked-record types.

No value heldNo source yet

No citation linked to this field yet.

Response for Data subcategories

Consent and use permissions

Specific use permissions separate from the 3D consent-level axis.

FieldCurrent valueEvidenceSource evidenceResponseNotes / correction

Consent and use permissions

Recommended

Confirm health/biomedical research use, industry/commercial consideration, non-commercial restrictions, governance modifiers, recontact, trial approach, biosample use, linkage, sharing, international transfer, and any Section 251/CAG support.

No value heldNo source yet

No citation linked to this field yet.

Response for Consent and use permissions

Access pathways

One or more routes by which researchers can request or analyse data.

FieldCurrent valueEvidenceSource evidenceResponseNotes / correction

Access pathways

Recommended

Confirm all data access pathways, including route, access level, TRE/SDE or download/API environment, DAC review, collaboration requirements, data sharing agreements, output checking, timelines, and fees.

No value heldNo source yet

No citation linked to this field yet.

Response for Access pathways

Within-cohort coverage

Aggregate counts or percentages showing how broadly data, consent, or access characteristics apply within the cohort.

FieldCurrent valueEvidenceSource evidenceResponseNotes / correction

Within-cohort coverage metrics

Recommended

Provide numerator, denominator, unit type, numerator/denominator exactness qualifiers, denominator type, basis, date/release, original source wording, and whether each metric is marginal, joint, conditional, or a release total.

No value heldNo source yet

No citation linked to this field yet.

Response for Within-cohort coverage metrics

Linkage and access

FieldCurrent valueEvidenceSource evidenceResponseNotes / correction
NHS linkage

Recommended

YesField-cited
  • ISRCTN API — ISRCTN47912798 (COVID-CNS)

    https://www.isrctn.com/api/query/format/default?q=47912798&limit=5

    Section: inclusion

    “Admitted to a UK hospital during the COVID-19 pandemic”

    Page: https://www.isrctn.com/ISRCTN47912798

Response for NHS linkage
GP linkage

Recommended

NoField-cited
  • ISRCTN API — ISRCTN47912798 (COVID-CNS)

    https://www.isrctn.com/api/query/format/default?q=47912798&limit=5

    Section: intervention/description

    “Baseline assessment at admission will comprise of;”

    Page: https://www.isrctn.com/ISRCTN47912798

Response for GP linkage
Death registry linkage

Recommended

NoField-cited
Response for Death registry linkage
Education linkage

Recommended

NoField-cited
Response for Education linkage
Data access mechanism

Recommended

direct_applicationField-cited
  • University of Liverpool — COVID-19 Clinical Neuroscience Study (about)

    https://www.liverpool.ac.uk/covid-clinical-neuroscience-study/about/

    Section: How do researchers access data and samples from the study?

    “Anyone interested in applying to access COVID-CNS data will need to complete a BioResource Data Access Application Form.”

    Page: https://www.liverpool.ac.uk/covid-clinical-neuroscience-study/about/

Response for Data access mechanism
TRE platform

Recommended

No value heldNot published
  • Searched — not published

    UNSOURCEABLE: access is described via BioResource application rather than a named TRE product.

Response for TRE platform
Data dictionary URL

Recommended

No value heldNot published
  • Searched — not published

    UNSOURCEABLE: no public data-dictionary URL located for the COVID-CNS researcher bundle on reviewed pages.

Response for Data dictionary URL
Data access timeline (days)

Recommended

No value heldNot published
  • Searched — not published

    UNSOURCEABLE: BioResource application timeline not quantified as days in sources reviewed.

Response for Data access timeline (days)
Data access cost

Recommended

No value heldNot published
  • Searched — not published

    UNSOURCEABLE: no public fee schedule in reviewed pages.

Response for Data access cost

Participant profile and dates

FieldCurrent valueEvidenceSource evidenceResponseNotes / correction
Age distribution

Recommended

No value heldNot published
  • Searched — not published

    UNSOURCEABLE in this pass: no cohort Table 1 age distribution extracted into downloaded files; only ISRCTN ageRange=Adult.

Response for Age distribution
Sex distribution

Recommended

No value heldNot published
  • Searched — not published

    UNSOURCEABLE in this pass: sex distribution not transcribed from full-text tables.

Response for Sex distribution
Ethnicity distribution

Recommended

No value heldNot published
  • Searched — not published

    UNSOURCEABLE in this pass: ethnicity distribution not transcribed from full-text tables.

Response for Ethnicity distribution
Smoking status distribution

Recommended

No value heldNo source yet

No citation linked to this field yet.

Response for Smoking status distribution
Median age

Recommended

No value heldNot published
  • Searched — not published

    UNSOURCEABLE in this pass: median age not extracted from outcomes paper HTML snapshot.

Response for Median age
Percent female

Recommended

No value heldNot published
  • Searched — not published

    UNSOURCEABLE in this pass: percent female not extracted from outcomes paper HTML snapshot.

Response for Percent female
Percent non-white

Recommended

No value heldNot published
  • Searched — not published

    UNSOURCEABLE in this pass: ethnicity percentages not extracted from outcomes paper HTML snapshot.

Response for Percent non-white
Geographic coverage

Recommended

multi_siteField-cited
Response for Geographic coverage
Follow-up duration

Recommended

3–9 months in-hospital and post-discharge follow-up (ISRCTN); longer-term outcome analyses in linked publicationsField-cited
  • ISRCTN API — ISRCTN47912798 (COVID-CNS)

    https://www.isrctn.com/api/query/format/default?q=47912798&limit=5

    Section: plainEnglishSummary

    “The study team will assess markers of brain injury, inflammation, and brain scan changes in these patients.”

    Page: https://www.isrctn.com/ISRCTN47912798

Response for Follow-up duration
Last data collection date

Recommended

No value heldNot published
  • Searched — not published

    UNSOURCEABLE: final data freeze date not stated as a single calendar date on reviewed pages.

Response for Last data collection date
Recruitment start date

Recommended

1 Feb 2021Field-cited
Response for Recruitment start date
Recruitment end date

Recommended

30 Apr 2022Field-cited
Response for Recruitment end date

Diagnosis areas

Mental health diagnosis areas represented in this cohort.

FieldCurrent valueEvidenceSource evidenceResponseNotes / correction
Diagnosis area: Major depressive disorder

Recommended

Confirm this diagnosis area applies and estimated N if shown.

Major depressive disorder · Mood DisordersField-cited
  • Shil et al. — COVID-CNS outcomes (Scientific Reports, 2025)

    https://doi.org/10.1038/s41598-024-80833-0

    Section: application/ld+json description

    “There was no significant difference in the proportion with depression or anxiety between case and control groups overall.”

    Page: https://doi.org/10.1038/s41598-024-80833-0

Response for Diagnosis area: Major depressive disorder
Diagnosis area: Generalised anxiety disorder

Recommended

Confirm this diagnosis area applies and estimated N if shown.

Generalised anxiety disorder · Anxiety DisordersField-cited
  • Shil et al. — COVID-CNS outcomes (Scientific Reports, 2025)

    https://doi.org/10.1038/s41598-024-80833-0

    Section: application/ld+json description

    “There was no significant difference in the proportion with depression or anxiety between case and control groups overall.”

    Page: https://doi.org/10.1038/s41598-024-80833-0

Response for Diagnosis area: Generalised anxiety disorder
Diagnosis area: Long COVID neuropsychiatric

Recommended

Confirm this diagnosis area applies and estimated N if shown.

Long COVID neuropsychiatric · OtherField-cited
  • ISRCTN API — ISRCTN47912798 (COVID-CNS)

    https://www.isrctn.com/api/query/format/default?q=47912798&limit=5

    Section: conditions/description

    “Acute brain complications of COVID-19 and their neurological, psychiatric, and cognitive sequelae”

    Page: https://www.isrctn.com/ISRCTN47912798

Response for Diagnosis area: Long COVID neuropsychiatric

Linked sites

Sites contributing participants or data to this cohort.

FieldCurrent valueEvidenceSource evidenceResponseNotes / correction
Linked site: NIHR Cambridge Biomedical Research Centre

Recommended

NIHR Cambridge Biomedical Research Centre · East of EnglandField-cited
  • ISRCTN API — ISRCTN47912798 (COVID-CNS)

    https://www.isrctn.com/api/query/format/default?q=47912798&limit=5

    Section: sponsor/organisation

    “Cambridge University Hospitals NHS Foundation Trust”

    Page: https://www.isrctn.com/ISRCTN47912798

Response for Linked site: NIHR Cambridge Biomedical Research Centre
Linked site: Institute of Psychiatry, Psychology & Neuroscience

Recommended

Institute of Psychiatry, Psychology & Neuroscience · LondonField-cited
Response for Linked site: Institute of Psychiatry, Psychology & Neuroscience
Linked site: University of Liverpool

Recommended

University of Liverpool · North West EnglandField-cited
Response for Linked site: University of Liverpool

Verification metadata

Internal catalogue status — for reference only.

FieldCurrent valueEvidenceSource evidenceResponseNotes / correction
Verification status

Recommended

unverifiedInternal

Internal catalogue field

——
Last verified

Recommended

16 Apr 2026Internal

Internal catalogue field

——
Data source

Recommended

Verified Apr 2026 from University of Liverpool COVID-CNS pages, NIHR BioResource NBR224 study page, ISRCTN47912798 XML API, KCL launch news, Scientific Reports outcomes paper (DOI 10.1038/s41598-024-80833-0), HDR UK Gateway search HTML, ClinicalTrials.gov API v2 (exact-title query returned 0 studies). DPUK website could not be reached from the verification environment (connection failed).Internal

Internal catalogue field

——